A new basic-translational research paper from our Land Michael Bader's group has been published: Legchenko et al. Novel Tryptophan Hydroxylase Inhibitor TPT-001 Reverses PAH, ... (2024). JACC Basic Transl Science.
jacc.org/doi/10.1016/j.jacbt…@3CPRCouncil@ATS_PC@PVRI@StanfordCVI
New paper from @Hansmann_Lab :
HUCMSC/HUCMSC-CM has the potential to become a real game changer in the treatment of severe PAH and RV failure, by driving regeneration, mitochondrial function, autophagy and anti-inflammation.
nature.com/articles/s44161-0…
NEW PAPER OUT:Hamberger F et al. Frontiers Cardiovasc Med, 2022. frontiersin.org/articles/10.…
Fibrogenic signature in patients with hepatic congestion due to heart disease: PAH patients should be screened for unrecognized liver fibrosis. #WorldPHDay,#hepatology, @3CPRCouncil, @ATS_PC